* Mesa Laboratories Inc MLAB.OQ reported quarterly adjusted
earnings of 70 cents per share for the quarter ended in
September. The mean expectation of four analysts for the quarter
was for earnings of 42 cents per share.
* Revenue fell 78.1% to $6.97 million from a year ago; analysts
expected $35.23 million.
* The mean earnings estimate of analysts had risen by
about 223.1% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Mesa Laboratories Inc shares had risen by 2.7% this
quarter and gained 8.3% so far this year.
* Wall Street's median 12-month price target for Mesa
Laboratories Inc is $320.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
This summary was machine generated November 4 at 05:26 p.m.
All figures in US dollars unless otherwise stated